- Kanamycin
- Kanamycin acid Sulfate
- Kanamycin acid sulfate
- Kanamycin B sulfate
- KANAMYCIN SULFATE
- Kanamycin sulfate
- 133934-09-51-Propanaminium,3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., inner salts
- 133935-06-52-Propenoic acid,telomer with ethenylbenzene, 2-propanol and sodium 4-ethenylbenzenesulfonate(1:1), sodium salt, peroxydisulfuric acid ([(HO)S(O)2]2O2) ammonium salt(1:2)-initiated
- 13393-64-11,5,9-Decatriene
- 13393-68-5Hydroperoxide,1,1-dimethylbutyl
- 133937-72-1NA
- 13393-93-61-Phenanthrenemethanol,tetradecahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R,4aR,4bS,10aR)-
- 133943-59-6L-Proline,L-leucyl-L-arginyl-
- 133950-70-6Nonanoic acid,5-bromo-1H-indol-3-yl ester
- 133950-71-7Decanoic acid,5-bromo-1H-indol-3-yl ester
- 133950-77-3Nonanoic acid,5-bromo-4-chloro-1H-indol-3-yl ester
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Kanamycin acid Sulfate |
EINECS | N/A |
| CAS No. | 133-92-6 | Density | N/A |
| PSA | 365.59000 | LogP | -4.06220 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C18H38N4O15S | Boiling Point | 809.5 °C at 760 mmHg |
| Molecular Weight | 582.584 | Flash Point | 443.4 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | 22-24/25 | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
KANAMYCIN A;KANAMYCIN SULPHATE;KANAMYCIN SULFATE WHITE;KANAMYCIN SULFATE, STREPTOMYCES KANAMYCETICUS;KANAMYCIN SULFATE SALT;KANAMYCIN MONOSULFATE;KANAMYCIN MONO SULPHATE;KANAMYCIN MONOSULFATE SALT |
Article Data | 2 |
Kanamycin acid Sulfate Specification
The Kanamycin acid Sulfate is an organic compound with the formula C18H38N4O15S. The IUPAC name of this chemical is 2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol; sulfuric acid. With the CAS registry number 133-92-6, it is also named as (1S,2R,3R,4S,6R)-4,6-Diamino-3-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside sulfate (1:1). The product's category is Antibiotics.
Physical properties about Kanamycin acid Sulfate are: (1)ACD/LogP: -2.58; (2)# of Rule of 5 Violations: 2; (3)#H bond acceptors: 15 #H bond donors: 15; (4)#Freely Rotating Bonds: 17; (5)Polar Surface Area: 114.49 Å2; (6)Flash Point: 443.4 °C; (7)Enthalpy of Vaporization: 134 kJ/mol; (8)Boiling Point: 809.5 °C at 760 mmHg; (9)Vapour Pressure: 2.47E-30 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: O=S(=O)(O)O.O([C@@H]2[C@@H](O)[C@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@@H](N)C[C@H]2N)[C@H]3O[C@@H]([C@@H](O)[C@H](N)[C@H]3O)CO
(2)InChI: InChI=1/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1
(3)InChIKey: OOYGSFOGFJDDHP-KMCOLRRFBH
(4)Std. InChI: InChI=1S/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1
(5)Std. InChIKey: OOYGSFOGFJDDHP-KMCOLRRFSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| child | TDLo | intramuscular | 390mg/kg (390mg/kg) | SENSE ORGANS AND SPECIAL SENSES: CHANGE IN ACUITY: EAR | Journal of Pediatrics. Vol. 60, Pg. 230, 1962. |
| mouse | LD50 | intramuscular | 1190mg/kg (1190mg/kg) | Drugs in Japan Vol. 6, Pg. 173, 1982. | |
| mouse | LD50 | intraperitoneal | 1353mg/kg (1353mg/kg) | Antimicrobial Agents and Chemotherapy Vol. -, Pg. 138, 1963. | |
| mouse | LD50 | intravenous | 240mg/kg (240mg/kg) | Drugs in Japan Vol. 6, Pg. 173, 1982. | |
| mouse | LD50 | oral | 17500mg/kg (17500mg/kg) | Drugs in Japan Vol. 6, Pg. 173, 1982. | |
| mouse | LD50 | subcutaneous | 1100mg/kg (1100mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Antibiotiki. Vol. 29, Pg. 851, 1984. |
| rabbit | LD50 | intramuscular | > 3gm/kg (3000mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rabbit | LD50 | intravenous | 550mg/kg (550mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rabbit | LD50 | oral | > 3gm/kg (3000mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rabbit | LD50 | subcutaneous | > 3gm/kg (3000mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rat | LD50 | intramuscular | > 4gm/kg (4000mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rat | LD50 | intraperitoneal | 3200mg/kg (3200mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rat | LD50 | intravenous | 225mg/kg (225mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rat | LD50 | oral | > 4gm/kg (4000mg/kg) | Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975. | |
| rat | LD50 | subcutaneous | 1700mg/kg (1700mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 12, Pg. 597, 1962. |
What can I do for you?
Get Best Price
